Rab11B

Emily Bruce's lab at the University of Vermont discovered that the Rab11B protein is critical for H3N2 flu virus infection, challenging the long-held belief that sialic acid is the primary binding point. This accidental finding could lead to more targeted antiviral treatments for influenza.

Researchers discovered that different flu strains use distinct strategies to enter human cells, revealing a potential method to block viral replication by targeting specific molecules. The study, led by Dr. Emily Bruce, found that depleting the Rab11B protein prevented H3N2 influenza from entering lung cells, challenging previous assumptions about uniform viral entry mechanisms.